Optimising growth hormone therapy in the NHS: Benefits of choosing and switching patients to cost-effective products to generate savings and treat more patients.
This is a promotional symposium organised and funded by Sandoz, which is intended for UK healthcare professionals only. Sandoz products will be discussed. UK | March 2024 | 417221
Churchill Room
Chair: Cheryl Taylor (Head of Market Access, Sandoz)